- Home
- ENLV vs ASPS Comparison
ENLV vs ASPS Comparison
Compare ENLV & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- ASPS
- Stock Information
- Founded
- ENLV 2005
- ASPS 1999
- Country
- ENLV Israel
- ASPS Luxembourg
- Employees
- ENLV N/A
- ASPS N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- ASPS Other Consumer Services
- Sector
- ENLV Health Care
- ASPS Consumer Discretionary
- Exchange
- ENLV Nasdaq
- ASPS Nasdaq
- Market Cap
- ENLV 20.7M
- ASPS N/A
- IPO Year
- ENLV 1995
- ASPS N/A
- Fundamental
- Price
- ENLV $0.98
- ASPS $0.85
- Analyst Decision
- ENLV Strong Buy
- ASPS
- Analyst Count
- ENLV 2
- ASPS 0
- Target Price
- ENLV $10.00
- ASPS N/A
- AVG Volume (30 Days)
- ENLV 63.1K
- ASPS 110.5K
- Earning Date
- ENLV 06-13-2025
- ASPS 05-06-2025
- Dividend Yield
- ENLV N/A
- ASPS N/A
- EPS Growth
- ENLV N/A
- ASPS N/A
- EPS
- ENLV N/A
- ASPS N/A
- Revenue
- ENLV N/A
- ASPS $160,134,000.00
- Revenue This Year
- ENLV N/A
- ASPS $38.29
- Revenue Next Year
- ENLV N/A
- ASPS N/A
- P/E Ratio
- ENLV N/A
- ASPS N/A
- Revenue Growth
- ENLV N/A
- ASPS 10.39
- 52 Week Low
- ENLV $0.81
- ASPS $0.43
- 52 Week High
- ENLV $1.84
- ASPS $2.11
- Technical
- Relative Strength Index (RSI)
- ENLV 53.70
- ASPS 56.58
- Support Level
- ENLV $0.87
- ASPS $0.78
- Resistance Level
- ENLV $0.91
- ASPS $0.86
- Average True Range (ATR)
- ENLV 0.06
- ASPS 0.10
- MACD
- ENLV 0.01
- ASPS 0.01
- Stochastic Oscillator
- ENLV 90.31
- ASPS 67.50
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.